Arrowhead Research | Zahlungsmittel Und Äquivalente



Cash And Equivalent Veränderung Datum
Agios Pharmaceuticals USD 80.87M 1.91M 2025-06
Alnylam Pharmaceuticals USD 1.11B 94.03M 2025-06
Arrowhead Research USD 129.79M 55.92M 2025-06
Incyte USD 2.42B 13.08M 2025-06
Ionis Pharmaceuticals USD 297.3M 33.11M 2025-06
Ligand Pharmaceuticals USD 67.67M 189.22M 2025-06
Merck USD 8.01B 622M 2025-06
Moderna USD 1.28B 344M 2025-06
Novartis USD 6.66B 410M 2025-06
Sarepta Therapeutics USD 510.6M 269.73M 2025-06
TG Therapeutics USD 278.86M 146.72M 2025-06
Ultragenyx Pharmaceutical USD 166.11M 396.9M 2025-06
Vertex Pharmaceuticals USD 6.38B 1.71B 2025-06
Xencor USD 44.44M 4.77M 2025-06


Arrowhead Research Zahlungsmittel Und Äquivalente - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.